Community Health Systems, Inc. (CYH) SEC Filings & Earnings Calls
EquiReason read 19 Community Health Systems, Inc. SEC filings in the last 12 months. Latest: 10-Q on 2026-07-23 — Q2 2026 net income fell 75% YoY to $70M, driven by divestitures, higher charity care, and salary inflation; same-store revenue grew 2.4%..
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 411.7M
- P/E TTM
- 1.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 28 Oct, in 4 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
23 Jul 202610-QQ2 2026 net income fell 75% YoY to $70M, driven by divestitures, higher charity care, and salary inflation; same-store revenue grew 2.4%.earningsopen
Figures in the filing · each found in the filing text
| Net operating revenues · Q2-2026 | $2.83B | -10% y/y |
| Net income attributable to Community Health Systems, Inc. stockholders · Q2-2026 | $70M | -75% y/y |
| Operating cash flow · H1-2026 | $-209M | |
| ABL availability · 2026-06-30 | $751M | |
| Same-store inpatient admissions change · Q2-2026 | 1.9% | |
| Same-store adjusted admissions change · Q2-2026 | 2.9% | |
| Capital expenditures · H1-2026 | $152M | -14% y/y |
| Net proceeds from divestitures · H1-2026 | $1.20B |
Guidance
2026 capex guided $350M-$400M
Management reaffirmed 2026 capex guidance of $350M-$400M; no formal revenue or earnings guidance provided.
Risks flagged
Medicaid/ACA coverage loss
“The 2025 Reconciliation Law includes healthcare policy changes that are expected to decrease access to health insurance and result in significant cuts to federal healthcare spending.” · word for word
Charity care cost increase
“The amount of foregone revenue related to providing charity care services as a percentage of net operating revenues was approximately 18.3% and 10.7% for the three months ended June 30, 2026 and 2025, respectively.” · word for word
Regulatory uncertainty from Supreme Court decisions
“These U.S. Supreme Court decisions increase judicial scrutiny of agency authority, shift greater responsibility for statutory interpretation to courts and expand the timeline in which a plaintiff can sue regulators.” · word for word
22 Jul 20268-K · 2.02, 7.01Net operating revenues $2.83B (-10% y/y); Net income attributable to stockholders $70M (-75% y/y); Diluted EPS (GAAP) $0.51 (-76% y/y); Guidance: Updated annual earnings guidance included in press release (specific numbers not in excerpt)earningsopen
Figures in the filing · each found in the filing text
| Net operating revenues · Q2-2026 | $2.83B | -10% y/y |
| Net income attributable to stockholders · Q2-2026 | $70M | -75% y/y |
| Diluted EPS (GAAP) · Q2-2026 | $0.51 | -76% y/y |
| Adjusted diluted EPS (non-GAAP) · Q2-2026 | $-0.19 | |
| Adjusted EBITDA · Q2-2026 | $330M | -13% y/y |
| Net cash provided by operating activities · Q2-2026 | $87M | 0% y/y |
| Same-store admissions change · Q2-2026 | 1.9% | |
| Same-store adjusted admissions change · Q2-2026 | 2.9% |
Guidance
Updated annual earnings guidance included in press release (specific numbers not in excerpt)
Updated annual guidance reflects lower earnings expectations due to divestitures, payor mix, and cost pressures.
Risks flagged
Payor mix deterioration pressuring margins; higher proportion of government/less profitable payors.
“Unfavorable change in payor mix cited as key driver of Adjusted EBITDA decline.”
Medical specialist fee inflation adding cost pressure.
“Higher medical specialist fees cited as key driver of Adjusted EBITDA decline.”
Divestiture strategy reduces scale and may impact long-term revenue growth.
“Total revenue -9.8% primarily due to divestitures; same-store growth +2.4% insufficient to offset.”
1 Jun 20268-K · 2.01, 8.01Completed an acquisition or disposition of significant assets; disclosed a material event under other events (litigation, recall, contract loss, or major announcement)acquisitionopen
Risks flagged
Loss of revenue and earnings contribution from divested hospitals may pressure overall financial performance.
“Pro forma financial statements required due to significant disposition.”
6 May 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
High coupon debt (10.875% 2032 Notes) suggests elevated interest burden; tender may reduce leverage.
“Tender offer includes 10.875% Senior Secured Notes due 2032.”
23 Apr 20268-K · 8.01Disclosed a material event under other events (litigation, recall, contract loss, or major announcement); filed financial statements and exhibits with this reportopen
Risks flagged
High coupon debt (10.875% 2032 Notes) suggests elevated interest burden; tender may reduce leverage.
“Tender offer includes 10.875% Senior Secured Notes due 2032.”
22 Apr 202610-QNet Operating Revenues $2.96B (-6% y/y); Net Loss Attributable to Stockholders $-58M (+346% y/y); Same-Store Net Operating Revenues Growth 3.1; Guidance: 2026 capital expenditures expected $350M to $400Mopen
Figures in the filing · each found in the filing text
| Net Operating Revenues · Q1-2026 | $2.96B | -6% y/y |
| Net Loss Attributable to Stockholders · Q1-2026 | $-58M | +346% y/y |
| Same-Store Net Operating Revenues Growth · Q1-2026 | 3.1% | |
| Same-Store Inpatient Admissions Growth · Q1-2026 | -1.3% | |
| Same-Store Adjusted Admissions Growth · Q1-2026 | -0.5% | |
| Capital Expenditures · Q1-2026 | $76M | -11% y/y |
| ABL Availability · Q1-2026 | $824M | |
| Total Debt · Q1-2026 | $10.20B |
Guidance
2026 capital expenditures expected $350M to $400M
Management reaffirmed 2026 capex guidance of $350M-$400M, but did not provide explicit revenue or margin guidance.
Risks flagged
Medicaid Funding Reduction
“We expect the law to adversely impact our revenue and financial results as well as increase the amount of our self-pay patients, including as a result of this legislation’s limitations on Medicaid eligibility and reductions in federal Medicaid funding as noted above.” · word for word
Negative Operating Cash Flow
“Net cash provided by operating activities changed by $417 million, from approximately $120 million of cash provided by operating activities for the three months ended March 31, 2025, to cash used in operating activities of approximately $297 million for the three months ended March 31, 2026.” · word for word
High Leverage
“As of March 31, 2026, approximately $29 million of our outstanding debt of approximately $10.2 billion is due within the next 12 months.” · word for word
21 Apr 20268-K · 2.02, 7.01Net operating revenues $2.96B (-6% y/y); Net loss attributable to Community Health Systems, Inc. stockholders $-58M; Loss per share (diluted) $-0.43earningsopen
Figures in the filing · each found in the filing text
| Net operating revenues · Q1-2026 | $2.96B | -6% y/y |
| Net loss attributable to Community Health Systems, Inc. stockholders · Q1-2026 | $-58M | |
| Loss per share (diluted) · Q1-2026 | $-0.43 | |
| Adjusted EBITDA · Q1-2026 | $309M | -18% y/y |
| Net cash used in operating activities · Q1-2026 | $-297M | |
| Same-store admissions change · Q1-2026 | -1.3% | |
| Same-store adjusted admissions change · Q1-2026 | -0.5% |
Risks flagged
Divestiture of multiple hospitals reduces revenue base and creates transition risk.
“During 2026, through the date of this press release, the Company divested three hospitals as well as its 80% ownership interest in one other hospital, all effective on February 1, 2026, and divested one other hospital, effective April 1, 2026.” · word for word
Unfavorable payor mix and lower same-store volumes driving margin compression.
“lower same-store volumes, an unfavorable change in payor mix” · word for word
Negative operating cash flow of $297M raises liquidity concerns.
“Net cash used in operating activities was $297 million” · word for word
2 Apr 2026DEF 14AAnnual proxy statement disclosing executive compensation, governance, and 2025 financial results.open
Figures in the filing · each found in the filing text
| Net Operating Revenue · FY2025 | $12.48B | |
| Adjusted EBITDA · FY2025 | $1.53B | -1% y/y |
| Net Income (Loss) Attributable to Stockholders · FY2025 | $509M | |
| Adjusted EBITDA Margin Improvement · FY2025 | 0.0% | |
| Cumulative Same-Store Net Revenue Growth (3-year) · 2023-2025 | 15.0% | |
| Adjusted Diluted EPS · FY2025 | $1.19 |
Risks flagged
High Leverage
“The Company completed multiple debt offerings and tender offers to manage its capital structure, indicating high leverage.”
Operating Environment Challenges
“Despite ongoing challenges in the operating environment in 2025” · word for word
CEO Transition Risk
“Mr. Hingtgen retired as CEO on September 30, 2025. Mr. Hammons was appointed CEO on December 10, 2025.”
1 Apr 20268-K · 2.01, 8.01Purchase price $459Macquisitionopen
Figures in the filing · each found in the filing text
| purchase price · point_in_time | $459M |
Risks flagged
Loss of revenue and earnings from divested hospital; proceeds may be used for debt reduction, but future earnings base is reduced.
“Sale of Crestwood Medical Center and associated outpatient centers; pro forma financials filed.”
5 Mar 20268-K · 1.01, 8.01Community Health Systems (CHS) entered an Asset Purchase Agreement to sell four Arkansas hospitals to Freeman Health System for $112M, expected to close Q2 2026. CHS is the seller (target of divestiture).being acquiredopen
Figures in the filing · each found in the filing text
| Purchase price for hospital assets · Q2-2026 | $112M |
Risks flagged
Transaction subject to closing conditions and may not close; potential disruption from divestiture.
“closing of the Transaction is subject to the satisfaction or waiver of certain closing conditions” · word for word
19 Feb 202610-KNet operating revenues $12.48B (-1% y/y); Net income (loss) attributable to Community Health Systems, Inc. stockholders $509M (+199% y/y); Adjusted EBITDA $1.53B (-1% y/y)open
Figures in the filing · each found in the filing text
| Net operating revenues · FY2025 | $12.48B | -1% y/y |
| Net income (loss) attributable to Community Health Systems, Inc. stockholders · FY2025 | $509M | +199% y/y |
| Adjusted EBITDA · FY2025 | $1.53B | -1% y/y |
| Adjusted EBITDA as a % of net operating revenues · FY2025 | 12.2% | |
| Net cash flows provided by operating activities · FY2025 | $543M | +13% y/y |
| Same-store net operating revenues · FY2025 | $12.23B | +5% y/y |
| Same-store inpatient admissions · FY2025 | 392,348 | +2% y/y |
| Same-store adjusted admissions · FY2025 | 881,808 | +1% y/y |
| Licensed beds (at end of period) · FY2025 | 10,458 | -8% y/y |
| Admissions · FY2025 | 399,255 | -5% y/y |
Risks flagged
Medicaid funding cuts from 2025 Reconciliation Law
“Although we are unable to fully assess the magnitude of the future impact of the 2025 Reconciliation Law, we expect the law to adversely impact our revenue and financial results as well as increase the amount of our self-pay patients, including as a result of this legislation's limitations on Medicaid eligibility and reductions in federal Medicaid funding as” · word for word
High leverage and debt service burden
“Interest expense, net, increased by $10 million to $870 million for the year ended December 31, 2025 compared to $860 million for the same period in 2024.” · word for word
Cybersecurity and data breach risk
“In particular, on February 13, 2023, we disclosed a security incident in which a third-party vendor who provides a secure file transfer software platform utilized by our subsidiaries experienced a security breach whereby PHI and personal information of certain patients of our healthcare facilities were exposed to an unauthorized third party.” · word for word
18 Feb 20268-K · 2.02, 7.01Net Operating Revenues $3.11B (-5% y/y); Net Income $110M; Adjusted EBITDA $395M (-8% y/y)earningsopen
Figures in the filing · each found in the filing text
| Net Operating Revenues · Q4-2025 | $3.11B | -5% y/y |
| Net Income · Q4-2025 | $110M | |
| Adjusted EBITDA · Q4-2025 | $395M | -8% y/y |
| Net Cash Provided by Operating Activities · Q4-2025 | $266M | +23% y/y |
| Same-Store Admissions Change · Q4-2025 | -0.3% | |
| Same-Store Adjusted Admissions Change · Q4-2025 | -0.3% | |
| Diluted EPS · Q4-2025 | $0.81 |
Risks flagged
Decline in reported revenue due to divestitures may indicate portfolio restructuring risk.
“Net operating revenues decreased 4.9% due to divestitures.”
Same-store admissions decline of 0.3% suggests potential volume pressure.
“Same-store admissions decreased 0.3%.”
11 Feb 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Organizational restructuring and executive departures may indicate management instability or strategic shift.
“Former CEO retired Sep 2025; former President retired Dec 2024; one executive ceased to be an officer due to organizational changes effective May 2025.”
2 Feb 20268-K · 2.01, 8.01Sale proceeds $623M; Additional distribution $23Macquisitionopen
Figures in the filing · each found in the filing text
| Sale proceeds · 2026-02-01 | $623M | |
| Additional distribution · 2026-02-01 | $23M |
Risks flagged
Reduction in hospital portfolio scale
“Sale of 80% interest in Tennova Healthcare - Clarksville”
20 Jan 20268-K · 1.01, 8.01Community Health Systems agreed to sell Crestwood Medical Center assets to Huntsville Hospital Health System for $450M; expected close Q2 2026.being acquiredopen
Figures in the filing · each found in the filing text
| Purchase price · Crestwood Medical Center · Q2-2026 | $450M |
Risks flagged
Transaction subject to closing conditions; risk of non-completion or delay.
“closing of the Transaction is subject to the satisfaction or waiver of certain closing conditions” · word for word
10 Dec 20258-K · 5.02Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this reportopen
Risks flagged
Leadership transition risk, but no specifics on departure reason or successor.
“Press release announcing departure of a director or principal officer.”
2 Dec 20258-K · 2.01, 8.01Purchase price $194Macquisitionopen
Figures in the filing · each found in the filing text
| purchase price · ambulatory outreach business · Q4-2025 | $194M |
Risks flagged
Sale reduces revenue base from ambulatory outreach services, though likely non-core.
“Purchaser acquired from certain subsidiaries of CHS the select assets and assumed certain leases of CHS’s ambulatory outreach business across 13 states” · word for word
31 Oct 20258-K · 1.01, 8.01Purchase Price $600Mopen
Figures in the filing · each found in the filing text
| Purchase Price · 2026 | $600M |
Risks flagged
Transaction subject to regulatory approvals and closing conditions; may not close on expected timeline.
“Consummation of the Transaction is expected to occur in early 2026, subject to regulatory approvals and closing conditions.” · word for word
24 Oct 202510-QQ3 2025 net income of $171M vs net loss of $(355)M in Q3 2024, driven by lower impairment charges, a tax benefit, and improved operating margins.earningsopen
Figures in the filing · each found in the filing text
| Net operating revenues · Q3-2025 | $3.09B | -0% y/y |
| Net income (loss) attributable to Community Health Systems, Inc. stockholders · Q3-2025 | $130M | +133% y/y |
| Operating cash flow · 9M-2025 | $277M | +5% y/y |
| ABL availability · 2025-09-30 | $806M | |
| Asset proceeds from sale · 9M-2025 | $1.00B | |
| Capital expenditures · 9M-2025 | $241M | -4% y/y |
| Same-store net operating revenues growth · Q3-2025 | 6.0% | |
| Same-store inpatient admissions growth · Q3-2025 | 1.3% | |
| Same-store adjusted admissions growth · Q3-2025 | 0.3% |
Guidance
Capital expenditures guided to $350M-$400M for 2025
Capital expenditure guidance of $350M-$400M for 2025; no revenue or earnings guidance provided, but management tone is positive given improved operating results.
Risks flagged
Medicaid funding cuts from 2025 Reconciliation Law
“Although we are unable to fully assess the magnitude of the future impact of the 2025 Reconciliation Law, we expect the 2025 Reconciliation Law as described above to adversely impact our revenue and financial results as well as increase the amount of our self-pay patients, including as a result of this legislation's limitations on Medicaid eligibility and re” · word for word
Medicare payment reductions from sequestration and outpatient PPS changes
“a Medicare spending reduction of up to 4% is required to take effect in early 2026, absent congressional action.” · word for word
Regulatory uncertainty from Supreme Court decisions and executive actions
“Regulatory uncertainty has increased as a result of recent decisions issued by the U.S. Supreme Court that affect review of federal agency actions, including Loper Bright Enterprises v. Raimondo, and the outcome of the 2024 federal elections.” · word for word
High leverage and refinancing risk
“As of September 30, 2025, approximately $16 million of our outstanding debt of approximately $10.6 billion is due within the next 12 months.” · word for word
Community Health Systems, Inc. — questions
- What did Community Health Systems, Inc. file recently?
- 19 SEC filings in the last 12 months. Latest: 10-Q on 2026-07-23 — Q2 2026 net income fell 75% YoY to $70M, driven by divestitures, higher charity care, and salary inflation; same-store revenue grew 2.4%.
Every figure on this page comes from Community Health Systems, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.